摘要 |
The present invention relates to new compounds of formula (I) or salts, solvates or solvated salts thereof, wherein Q, X, Y, Z, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP> and m, n and p are defined as in claim 1, processes for their preparation and to new intermediates used in the preparation thereof, pharmaceutical compositions comprising said compounds and to the use of said compounds as modulators of chemokine receptor activity in the treatment of airway diseases, inflammatory diseases, COPD and asthma. |